APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nasal Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nasal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchNasal Vaccines Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Nasal Vaccines Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Nasal Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nasal Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nasal Vaccines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Nasal Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nasal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nasal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nasal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nasal Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nasal Vaccines include Abbott, Sanofi, GlaxoSmithKline, AstraZeneca, Serum Institute of India, PharmaJet and Crossject, INJEX Pharma GmbH, BioDiem and Bharat Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nasal Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nasal Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nasal Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nasal Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Nasal Vaccines Segment by Company

Abbott

Sanofi

GlaxoSmithKline

AstraZeneca

Serum Institute of India

PharmaJet and Crossject

INJEX Pharma GmbH

BioDiem

Bharat Biotech

Antares Pharma

Nasal Vaccines Segment by Type

Flu Vaccines

COVID-19 Vaccines

Other Vaccines

Nasal Vaccines Segment by Application

Adult

Children

Nasal Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nasal Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nasal Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nasal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Nasal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Nasal Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Nasal Vaccines Industry Trends Table 2. Nasal Vaccines Industry Drivers Table 3. Nasal Vaccines Industry Opportunities and Challenges Table 4. Nasal Vaccines Industry Restraints Table 5. Global Nasal Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nasal Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Nasal Vaccines Sales by Manufacturers (K Doses) & (2021-2026) Table 8. Global Nasal Vaccines Sales Market Share by Manufacturers Table 9. Global Nasal Vaccines Average Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 10. Global Nasal Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nasal Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nasal Vaccines Manufacturers, Product Type & Application Table 13. Global Nasal Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nasal Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Flu Vaccines Table 17. Major Manufacturers of COVID-19 Vaccines Table 18. Major Manufacturers of Other Vaccines Table 19. Global Nasal Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Doses) Table 20. Global Nasal Vaccines Sales by Type (2021-2026) & (K Doses) Table 21. Global Nasal Vaccines Sales by Type (2027-2032) & (K Doses) Table 22. Global Nasal Vaccines Sales Market Share by Type (2021-2026) Table 23. Global Nasal Vaccines Sales Market Share by Type (2027-2032) Table 24. Global Nasal Vaccines Revenue by Type 2021 VS 2025 VS 2032 (K Doses) Table 25. Global Nasal Vaccines Revenue by Type (2021-2026) & (K Doses) Table 26. Global Nasal Vaccines Revenue by Type (2027-2032) & (K Doses) Table 27. Global Nasal Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global Nasal Vaccines Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Adult Table 30. Major Manufacturers of Children Table 31. Global Nasal Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Doses) Table 32. Global Nasal Vaccines Sales by Application (2021-2026) & (K Doses) Table 33. Global Nasal Vaccines Sales by Application (2027-2032) & (K Doses) Table 34. Global Nasal Vaccines Sales Market Share by Application (2021-2026) Table 35. Global Nasal Vaccines Sales Market Share by Application (2027-2032) Table 36. Global Nasal Vaccines Revenue by Application 2021 VS 2025 VS 2032 (K Doses) Table 37. Global Nasal Vaccines Revenue by Application (2021-2026) & (K Doses) Table 38. Global Nasal Vaccines Revenue by Application (2027-2032) & (K Doses) Table 39. Global Nasal Vaccines Revenue Market Share by Application (2021-2026) Table 40. Global Nasal Vaccines Revenue Market Share by Application (2027-2032) Table 41. Global Nasal Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Table 42. Global Nasal Vaccines Sales by Region (2021-2026) & (K Doses) Table 43. Global Nasal Vaccines Sales Market Share by Region (2021-2026) Table 44. Global Nasal Vaccines Sales Forecasted by Region (2027-2032) & (K Doses) Table 45. Global Nasal Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Nasal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 47. North America Nasal Vaccines Sales by Country (2021-2026) & (K Doses) Table 48. North America Nasal Vaccines Sales by Country (2027-2032) & (K Doses) Table 49. Europe Nasal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 50. Europe Nasal Vaccines Sales by Country (2021-2026) & (K Doses) Table 51. Europe Nasal Vaccines Sales by Country (2027-2032) & (K Doses) Table 52. Asia Pacific Nasal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 53. Asia Pacific Nasal Vaccines Sales by Country (2021-2026) & (K Doses) Table 54. Asia Pacific Nasal Vaccines Sales by Country (2027-2032) & (K Doses) Table 55. South America, Middle East and Africa Nasal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 56. South America, Middle East and Africa Nasal Vaccines Sales by Country (2021-2026) & (K Doses) Table 57. South America, Middle East and Africa Nasal Vaccines Sales by Country (2027-2032) & (K Doses) Table 58. Global Nasal Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Nasal Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Nasal Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Nasal Vaccines Revenue Market Share by Region (2021-2026) Table 62. Global Nasal Vaccines Revenue Market Share by Region (2027-2032) Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Nasal Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Abbott Nasal Vaccines Product Portfolio Table 67. Abbott Recent Development Table 68. Sanofi Company Information Table 69. Sanofi Business Overview Table 70. Sanofi Nasal Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Sanofi Nasal Vaccines Product Portfolio Table 72. Sanofi Recent Development Table 73. GlaxoSmithKline Company Information Table 74. GlaxoSmithKline Business Overview Table 75. GlaxoSmithKline Nasal Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline Nasal Vaccines Product Portfolio Table 77. GlaxoSmithKline Recent Development Table 78. AstraZeneca Company Information Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Nasal Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. AstraZeneca Nasal Vaccines Product Portfolio Table 82. AstraZeneca Recent Development Table 83. Serum Institute of India Company Information Table 84. Serum Institute of India Business Overview Table 85. Serum Institute of India Nasal Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Serum Institute of India Nasal Vaccines Product Portfolio Table 87. Serum Institute of India Recent Development Table 88. PharmaJet and Crossject Company Information Table 89. PharmaJet and Crossject Business Overview Table 90. PharmaJet and Crossject Nasal Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. PharmaJet and Crossject Nasal Vaccines Product Portfolio Table 92. PharmaJet and Crossject Recent Development Table 93. INJEX Pharma GmbH Company Information Table 94. INJEX Pharma GmbH Business Overview Table 95. INJEX Pharma GmbH Nasal Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. INJEX Pharma GmbH Nasal Vaccines Product Portfolio Table 97. INJEX Pharma GmbH Recent Development Table 98. BioDiem Company Information Table 99. BioDiem Business Overview Table 100. BioDiem Nasal Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. BioDiem Nasal Vaccines Product Portfolio Table 102. BioDiem Recent Development Table 103. Bharat Biotech Company Information Table 104. Bharat Biotech Business Overview Table 105. Bharat Biotech Nasal Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Bharat Biotech Nasal Vaccines Product Portfolio Table 107. Bharat Biotech Recent Development Table 108. Antares Pharma Company Information Table 109. Antares Pharma Business Overview Table 110. Antares Pharma Nasal Vaccines Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Antares Pharma Nasal Vaccines Product Portfolio Table 112. Antares Pharma Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Nasal Vaccines Distributors List Table 116. Nasal Vaccines Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Nasal Vaccines Product Image Figure 2. Global Nasal Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nasal Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Nasal Vaccines Sales (2021-2032) & (K Doses) Figure 5. Global Nasal Vaccines Average Price (US$/Dose) & (2021-2032) Figure 6. Global Top 5 and 10 Nasal Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Flu Vaccines Image Figure 9. COVID-19 Vaccines Image Figure 10. Other Vaccines Image Figure 11. Global Nasal Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 12. Global Nasal Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Nasal Vaccines Sales Market Share by Type (2021-2032) Figure 14. Global Nasal Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 15. Global Nasal Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Nasal Vaccines Revenue Market Share by Type (2021-2032) Figure 17. Adult Image Figure 18. Children Image Figure 19. Global Nasal Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 20. Global Nasal Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Nasal Vaccines Sales Market Share by Application (2021-2032) Figure 22. Global Nasal Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 23. Global Nasal Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Nasal Vaccines Revenue Market Share by Application (2021-2032) Figure 25. North America Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 26. North America Nasal Vaccines Sales Market Share by Country (2021-2032) Figure 27. U.S. Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 28. Canada Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 29. Mexico Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 30. Europe Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 31. Europe Nasal Vaccines Sales Market Share by Country (2021-2032) Figure 32. Germany Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 33. France Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 34. U.K. Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 35. Italy Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 36. Netherlands Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 37. Asia Pacific Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 38. Asia Pacific Nasal Vaccines Sales Market Share by Country (2021-2032) Figure 39. China Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 40. Japan Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 41. South Korea Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 42. Southeast Asia Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 43. India Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 44. Australia Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 45. South America, Middle East and Africa Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 46. South America, Middle East and Africa Nasal Vaccines Sales Market Share by Country (2021-2032) Figure 47. Brazil Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 48. South Africa Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 49. Saudi Arabia Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 50. Turkey Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 51. Argentina Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 52. UAE Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 53. Egypt Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 54. Chile Nasal Vaccines Sales and Growth Rate (2021-2032) & (K Doses) Figure 55. Global Nasal Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Nasal Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Nasal Vaccines Revenue (2021-2032) & (US$ Million) Figure 58. North America Nasal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Nasal Vaccines Revenue (2021-2032) & (US$ Million) Figure 60. Europe Nasal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Nasal Vaccines Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Nasal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Nasal Vaccines Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Nasal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Nasal Vaccines Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Nasal Vaccines Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Flu Vaccines
  • COVID-19 Vaccines
  • Other Vaccines
Applications
  • Adult
  • Children
Companies covered
  • Abbott
  • Sanofi
  • GlaxoSmithKline
  • AstraZeneca
  • Serum Institute of India
  • PharmaJet and Crossject
  • INJEX Pharma GmbH
  • BioDiem
  • Bharat Biotech
  • Antares Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nasal Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nasal Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Nasal Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Nasal Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Nasal Vaccines Market Dynamics
  1. 2.1 Nasal Vaccines Industry Trends
  2. 2.2 Nasal Vaccines Industry Drivers
  3. 2.3 Nasal Vaccines Industry Opportunities and Challenges
  4. 2.4 Nasal Vaccines Industry Restraints
3 Nasal Vaccines Market by Manufacturers
  1. 3.1 Global Nasal Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Nasal Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Nasal Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Nasal Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nasal Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nasal Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Nasal Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nasal Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nasal Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nasal Vaccines Tier 1, Tier 2, and Tier 3
4 Nasal Vaccines Market by Type
  1. 4.1 Nasal Vaccines Type Introduction
  2. 4.1.1 Flu Vaccines
  3. 4.1.2 COVID-19 Vaccines
  4. 4.1.3 Other Vaccines
  5. 4.2 Global Nasal Vaccines Sales by Type
  6. 4.2.1 Global Nasal Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nasal Vaccines Sales by Type (2021-2032)
  8. 4.2.3 Global Nasal Vaccines Sales Market Share by Type (2021-2032)
  9. 4.3 Global Nasal Vaccines Revenue by Type
  10. 4.3.1 Global Nasal Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Nasal Vaccines Revenue by Type (2021-2032)
  12. 4.3.3 Global Nasal Vaccines Revenue Market Share by Type (2021-2032)
5 Nasal Vaccines Market by Application
  1. 5.1 Nasal Vaccines Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Nasal Vaccines Sales by Application
  5. 5.2.1 Global Nasal Vaccines Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Nasal Vaccines Sales by Application (2021-2032)
  7. 5.2.3 Global Nasal Vaccines Sales Market Share by Application (2021-2032)
  8. 5.3 Global Nasal Vaccines Revenue by Application
  9. 5.3.1 Global Nasal Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Nasal Vaccines Revenue by Application (2021-2032)
  11. 5.3.3 Global Nasal Vaccines Revenue Market Share by Application (2021-2032)
6 Global Nasal Vaccines Sales by Region
  1. 6.1 Global Nasal Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nasal Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Nasal Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Nasal Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nasal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nasal Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nasal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nasal Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Nasal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Nasal Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Nasal Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Nasal Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Nasal Vaccines Revenue by Region
  1. 7.1 Global Nasal Vaccines Revenue by Region
  2. 7.1.1 Global Nasal Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Nasal Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Nasal Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Nasal Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Nasal Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Nasal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Nasal Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Nasal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Nasal Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Nasal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Nasal Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Nasal Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Nasal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Nasal Vaccines Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Nasal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Nasal Vaccines Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline Nasal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Nasal Vaccines Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Nasal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Nasal Vaccines Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Serum Institute of India
  26. 8.5.1 Serum Institute of India Company Information
  27. 8.5.2 Serum Institute of India Business Overview
  28. 8.5.3 Serum Institute of India Nasal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Serum Institute of India Nasal Vaccines Product Portfolio
  30. 8.5.5 Serum Institute of India Recent Developments
  31. 8.6 PharmaJet and Crossject
  32. 8.6.1 PharmaJet and Crossject Company Information
  33. 8.6.2 PharmaJet and Crossject Business Overview
  34. 8.6.3 PharmaJet and Crossject Nasal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PharmaJet and Crossject Nasal Vaccines Product Portfolio
  36. 8.6.5 PharmaJet and Crossject Recent Developments
  37. 8.7 INJEX Pharma GmbH
  38. 8.7.1 INJEX Pharma GmbH Company Information
  39. 8.7.2 INJEX Pharma GmbH Business Overview
  40. 8.7.3 INJEX Pharma GmbH Nasal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 INJEX Pharma GmbH Nasal Vaccines Product Portfolio
  42. 8.7.5 INJEX Pharma GmbH Recent Developments
  43. 8.8 BioDiem
  44. 8.8.1 BioDiem Company Information
  45. 8.8.2 BioDiem Business Overview
  46. 8.8.3 BioDiem Nasal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BioDiem Nasal Vaccines Product Portfolio
  48. 8.8.5 BioDiem Recent Developments
  49. 8.9 Bharat Biotech
  50. 8.9.1 Bharat Biotech Company Information
  51. 8.9.2 Bharat Biotech Business Overview
  52. 8.9.3 Bharat Biotech Nasal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bharat Biotech Nasal Vaccines Product Portfolio
  54. 8.9.5 Bharat Biotech Recent Developments
  55. 8.10 Antares Pharma
  56. 8.10.1 Antares Pharma Company Information
  57. 8.10.2 Antares Pharma Business Overview
  58. 8.10.3 Antares Pharma Nasal Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Antares Pharma Nasal Vaccines Product Portfolio
  60. 8.10.5 Antares Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nasal Vaccines Value Chain Analysis
  2. 9.1.1 Nasal Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nasal Vaccines Production Mode & Process
  6. 9.2 Nasal Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nasal Vaccines Distributors
  9. 9.2.3 Nasal Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst